• With recent currency devaluation in Argentina, company points to lower half of full-year ongoing EPS guidance of $5.10 to $5.60; full year as-reported guidance improves modestly to $4.12 to $4.79 as a result of the anticipated timing of charges related to announced restructuring actions
• Finalizes plans to reach previously outlined target of $500 million of annual savings by end of FY18
• Company targets ongoing and as-reported EPS CAGR in excess of 20% from end of FY16 to FY19
• Industry-leading R&D pipeline delivers more than 20 advancements for third-consecutive year

Monsanto Company (NYSE: MON) delivered earnings per share (EPS) for the first quarter ahead of expectations as operating expenses and soybean sales in Brazil both were better than original expectations for the first quarter of fiscal year 2016. In 2016, the company continues to execute on key initiatives within its core seeds and traits business led by new global corn hybrid portfolio introductions and continued significant Intacta RR2 PRO™ soybean adoption. Monsanto also remains disciplined in the execution of its Agricultural Productivity strategy, further optimization of spend and acceleration of progress toward its targeted capital structure. In its annual research and development (R&D) update today, the company will highlight more than 20 phase advancements across the industry’s broadest pipeline focused on helping farmers address current and future challenges.

Full release